Stabilized polymeric nanocapsules, dispersions comprising the nanocapsules, and methods for the treatment of bacterial biofilms

US10493039B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10493039-B2
Application numberUS-201615757092-A
CountryUS
Kind codeB2
Filing dateAug 16, 2016
Priority dateSep 3, 2015
Publication dateDec 3, 2019
Grant dateDec 3, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A nanocapsule includes a liquid hydrophobic care including an essential oil, and a shell encapsulating the core. The shell includes a copolymer having repeating units of Formula (I) and (II) wherein X, L 1 , R 1 , R 2 , y, and p are as described herein. A dispersion is also disclosed, wherein the dispersion includes a plurality of nanocapsules. The nanocapsules described herein are particularly useful for the treatment of bacterial biofilms.

First claim

Opening claim text (preview).

The invention claimed is: 1. A nanocapsule comprising, a liquid hydrophobic core comprising an essential oil; and a shell encapsulating the core, the shell comprising a copolymer comprising repeating units of Formula (I) and (II) wherein X is independently at each occurrence —O—, —S—, —CH 2 —, —(CR 4 R 5 )—, or  wherein R 4 and R 5 are independently at each occurrence a C 1-6 alkyl group and R 6 and R 7 are independently at each occurrence hydrogen or a C 1-6 alkyl group; L 1 is independently at each occurrence a divalent group that is (—CH 2 —) z , wherein z is an integer from 1 to 10, a divalent a C 1-20 alkylene oxide group, or a divalent poly(C 1-6 alkylene oxide) group; R 1 is independently at each occurrence hydrogen, a C 1-12 alkylene group, or a —C(═O)—O—(C 1-6 alkyl) group; y is 2 or 3; p is 0 or 1; and R 2 is independently at each occurrence a C 1-12 alkylene group, a C 6-20 arylene group, a C 1-20 alkylene oxide group, a poly(C 1-6 alkylene oxide) group, or a zwitterionic group. 2. The nanocapsule of claim 1 , wherein the copolymer further comprises repeating units of Formula (III) wherein X is independently at each occurrence —O—, —S—, —CH 2 —, —(CR 4 R 5 )—, or  wherein R 4 and R 5 are independently at each occurrence a C 1-6 alkyl group and R 6 and R 7 are independently at each occurrence hydrogen or a C 1-6 alkyl group; L 2 is independently at each occurrence a divalent group that is (—CH 2 —) z , wherein z is an integer from 1 to 10, a divalent a C 1-20 alkylene oxide group, or a divalent poly(C 1-6 alkylene oxide) group; R 3 is independently at each occurrence hydrogen, a C 1-12 alkylene group, or a —C(═O)—O—(C 1-6 alkyl) group; a is 2 or 3; and b is 0 or 1. 3. The nanocapsule of claim 1 , wherein the copolymer further comprises repeating units of Formula (IV). 4. The nanocapsule of claim 1 , wherein the copolymer further comprises repeating units of Formula (V) wherein X is independently at each occurrence —O—, —S—, —CH 2 —, —(CR 4 R 5 )—, or  wherein R 4 and R 5 are independently at each occurrence a C 1-6 alkyl group and R 6 and R 7 are independently at each occurrence hydrogen or a C 1-6 alkyl group; R 2 is independently at each occurrence a C 1-12 alkylene group, a C 6-20 arylene group, a C 1-20 alkylene oxide group, a poly(C 1-6 alkylene oxide) group, or a zwitterionic group; and L 3 is a divalent group that is (—CH 2 —) z , wherein z is an integer from 1 to 10. 5. The nanocapsule of claim 1 , wherein the core further comprises a hydrophobic anhydride-containing polymer in an amount of 0.01 to 15 weight percent, based on the weight of the core, wherein the hydrophobic anhydride-containing polymer comprising repeating units of Formula (VI) wherein R 8 is independently at each occurrence a hydrogen, a C 1-20 alkyl group or a C 6-20 aryl group. 6. The nanocapsule of claim 5 , wherein at least a portion of the shell is crosslinked with the anhydride-containing polymer. 7. The nanocapsule of claim 1 , wherein the essential oil is selected from the group consisting of peppermint oil, oregano oil, thymol, menthol, methyl salicylate, eucalyptol, carvacrol, camphor, anethole, carvone, eugenol, isoeugenol, limonene, osimen, n-decyl alcohol, citronel, a-salpineol, methyl acetate, citronellyl acetate, methyl eugenol, cineol, linalool, ethyl linalaol, safrola vanillin, spearmint oil, lemon oil, orange oil, sage oil, rosemary oil, cinnamon oil, pimento oil, laurel oil, cedar leaf oil, clove oil, cilantro oil, coriander oil, or a combination thereof. 8. The nanocapsule of claim 2 , wherein the copolymer comprises 5 to 50 mole percent repeating units of Formula (I); 10 to 50 mole percent repeating units of Formula (II); and 25 to 45 mole percent repeating units of Formula (III); wherein mole percent of each component is based on the total moles of the copolymer. 9. The nanocapsule of claim 1 , wherein X is —O—; L 1 is propylene; R 1 is hydrogen; y is 3; p is 1; and R 2 is a C 1-20 alkylene oxide group. 10. The nanocapsule of claim 1 , wherein R 2 is a group having the structure wherein n is 1, 2, 3, or 4; and R 10 is hydrogen, methyl, or a C 1-6 alkylamino group. 11. The nanocapsule of claim 2 , wherein R 3 is hydrogen; L 2 is propylene; a is 3; and b is 1. 12. The nanocapsule of claim 1 , wherein the copolymer has a number average molecular weight of 3,000 to 100,000 Daltons. 13. The nanocapsule of claim 1 , comprising 90 to 99.9 weight percent of the core; and 0.1 to 10 weight percent of the shell; wherein weight percent is based on the total weight of the nanocapsule. 14. The nanocapsule of claim 1 , wherein the nanocapsule comprises 1 to 10 weight percent, based on the weight of the nanocapsule, of the core comprising carvacrol oil; and 90 to 99 weight percent, based on the weight of the nanocapsule, of the shell comprising the copolymer, wherein each occurrence of X is —O—; each occurrence of L 1 is propylene; each occurrence of R 1 is hydrogen; each occurrence of y is 3; each occurrence of p is 1; each occurrence of R 2 is a group having the structure wherein n is 4; and the nanocapsule has a diameter of 1 to 100 nanometers. 15. The nanocapsule of claim 2 , wherein the nanocapsule comprises 1 to 10 weight percent, based on the weight of the nanocapsule, of the core comprising 85 to 99.99 weight percent, based on the weight of the core, of carvacrol oil; and 0.01 to 15 weight percent, based on the weight of the core, of the hydrophobic anhydride containing polymer comprising repeating units of Formula (VI) wherein m is an integer from 1 to 16; and 90 to 99 weight percent, based on the weight of the nanocapsule, of the shell comprising the copolymer, wherein each occurrence of X is —O—; each occurrence of L 1 and L 2 are propylene; each occurrence of R 1 is hydrogen; each occurrence of y is 3; each occurrence of p is 1; each occurrence of R 2 is a group having the structure wherein n is 4; each occurrence of R 3 is hydrogen; each occurrence of

Assignees

Inventors

Classifications

  • Ring opening metathesis polymerisation [ROMP] · CPC title

  • having no condensed rings · CPC title

  • A61K9/5138Primary

    obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates · CPC title

  • of carbocyclic compounds containing one or more carbon-to-carbon double bonds in the ring · CPC title

  • Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10493039B2 cover?
A nanocapsule includes a liquid hydrophobic care including an essential oil, and a shell encapsulating the core. The shell includes a copolymer having repeating units of Formula (I) and (II) wherein X, L 1 , R 1 , R 2 , y, and p are as described herein. A dispersion is also disclosed, wherein the dispersion includes a plurality of nanocapsules. The nanocapsules described herein are particularly…
Who is the assignee on this patent?
Univ Massachusetts
What technology area does this patent fall under?
Primary CPC classification A61K9/5138. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).